Leighanne Oh is a Vice President at Ascenta Capital, focusing on investment opportunities. She has experience in biotech and life sciences investing, with prior roles at Novo Holdings, Sofinnova Investments, and Jefferies.
One email when Leighanne's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckLeighanne Oh is a Vice President at Ascenta Capital, focusing on investment opportunities. She has experience in biotech and life sciences investing, with prior roles at Novo Holdings, Sofinnova Investments, and Jefferies.
Leighanne Oh invests through Ascenta Capital, which writes checks of $10M to $30M.
Email [email protected], the firm's inbox for founders, and name Leighanne in the subject. A warm intro from a founder Ascenta Capital backed works better.
Analyst on the Healthcare Investment Banking team at Jefferies; SoBE Bioequities; private investor at Sofinnova Investments; Novo Holdings; investor at SoBE Bioequities; private investor at Sofinnova.
Last updated 2026-10-15. Is this you? Ask for a correction.